IL-21 and IL-21R are not required for development of Th17 cells and autoimmunity in vivo - PubMed (original) (raw)
IL-21 and IL-21R are not required for development of Th17 cells and autoimmunity in vivo
Ivo Sonderegger et al. Eur J Immunol. 2008 Jul.
Free article
Abstract
Th17 cells have been recognized as the central effectors in organ-related autoimmune diseases. IL-6 is a key factor that reciprocally regulates Th17 and Foxp3(+) Treg differentiation by inhibition of TGF-beta induced Foxp3 and induction of RORgammat, a Th17 lineage-specific transcription factor. Recently IL-21 has been suggested to induce RORgammat and Th17 development in the absence of IL-6. However, the relevance of IL-21 for Th17-dependent inflammatory responses in vivo remains unclear. In this study, we demonstrate that differentiation of IL-17-producing CD4 T cells, their recruitment to inflamed organs, and the development of autoimmune disease was not affected in il21R(-/-) and il21(-/-) mice in models of myelin oligodendrocyte glycoprotein-induced autoimmune encephalitis and autoimmune myocarditis. IL-6 induced Th17 differentiation independent of and much more potently than IL-21 in vitro. These data suggest that IL-6 is sufficient to drive Th17 development and associated autoimmunity in vivo in the absence of IL-21 or IL-21R.
Comment in
- IL-21 and autoimmune disease--hypothesis and reality?
Holmdahl R. Holmdahl R. Eur J Immunol. 2008 Jul;38(7):1800-2. doi: 10.1002/eji.200838529. Eur J Immunol. 2008. PMID: 18546147
Similar articles
- IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
Nishihara M, Ogura H, Ueda N, Tsuruoka M, Kitabayashi C, Tsuji F, Aono H, Ishihara K, Huseby E, Betz UA, Murakami M, Hirano T. Nishihara M, et al. Int Immunol. 2007 Jun;19(6):695-702. doi: 10.1093/intimm/dxm045. Epub 2007 May 9. Int Immunol. 2007. PMID: 17493959 - The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells.
Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, Cua DJ, Littman DR. Ivanov II, et al. Cell. 2006 Sep 22;126(6):1121-33. doi: 10.1016/j.cell.2006.07.035. Cell. 2006. PMID: 16990136 - Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity.
Sutton CE, Lalor SJ, Sweeney CM, Brereton CF, Lavelle EC, Mills KH. Sutton CE, et al. Immunity. 2009 Aug 21;31(2):331-41. doi: 10.1016/j.immuni.2009.08.001. Epub 2009 Aug 13. Immunity. 2009. PMID: 19682929 - IL-6: regulator of Treg/Th17 balance.
Kimura A, Kishimoto T. Kimura A, et al. Eur J Immunol. 2010 Jul;40(7):1830-5. doi: 10.1002/eji.201040391. Eur J Immunol. 2010. PMID: 20583029 Review. - Th17 Cells and autoimmune encephalomyelitis (EAE/MS).
Aranami T, Yamamura T. Aranami T, et al. Allergol Int. 2008 Jun;57(2):115-20. doi: 10.2332/allergolint.R-07-159. Allergol Int. 2008. PMID: 18427164 Review.
Cited by
- Delimiting MOGAD as a disease entity using translational imaging.
Oertel FC, Hastermann M, Paul F. Oertel FC, et al. Front Neurol. 2023 Dec 7;14:1216477. doi: 10.3389/fneur.2023.1216477. eCollection 2023. Front Neurol. 2023. PMID: 38333186 Free PMC article. Review. - Unleashing nature's potential and limitations: Exploring molecular targeted pathways and safe alternatives for the treatment of multiple sclerosis (Review).
Fathallah S, Abdellatif A, Saadeldin MK. Fathallah S, et al. Med Int (Lond). 2023 Aug 17;3(5):42. doi: 10.3892/mi.2023.102. eCollection 2023 Sep-Oct. Med Int (Lond). 2023. PMID: 37680650 Free PMC article. Review. - TREM-2 Drives Development of Multiple Sclerosis by Promoting Pathogenic Th17 Polarization.
Qu S, Hu S, Xu H, Wu Y, Ming S, Zhan X, Wang C, Huang X. Qu S, et al. Neurosci Bull. 2024 Jan;40(1):17-34. doi: 10.1007/s12264-023-01094-x. Epub 2023 Jul 27. Neurosci Bull. 2024. PMID: 37498431 - Intricacies of TGF-β signaling in Treg and Th17 cell biology.
Wang J, Zhao X, Wan YY. Wang J, et al. Cell Mol Immunol. 2023 Sep;20(9):1002-1022. doi: 10.1038/s41423-023-01036-7. Epub 2023 May 23. Cell Mol Immunol. 2023. PMID: 37217798 Free PMC article. Review. - Cholinergic control of Th17 cell pathogenicity in experimental autoimmune encephalomyelitis.
Nechanitzky R, Nechanitzky D, Ramachandran P, Duncan GS, Zheng C, Göbl C, Gill KT, Haight J, Wakeham AC, Snow BE, Bradaschia-Correa V, Ganguly M, Lu Z, Saunders ME, Flavell RA, Mak TW. Nechanitzky R, et al. Cell Death Differ. 2023 Feb;30(2):407-416. doi: 10.1038/s41418-022-01092-y. Epub 2022 Dec 17. Cell Death Differ. 2023. PMID: 36528755 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials